Device data
Health topic Child mortality
Classification Treatment
Scope Clinical trial
Manufacturer
location
Malawi

Respiratory distress syndrome (RDS) is a major cause of child mortality. It is often treated using bubble CPAP (bCPAP), but these devices can cost thousands of dollars and are too expensive for low-resource settings.

Detailed description of the solution

This bCPAP technology uses low-cost aquarium pumps to generate continuous positive airway pressure (CPAP). This keeps the infant's lungs inflated, which allows them to breathe easier. This technology can be sold for as low as $160, which an estimated maintenance of only 25 cents every two years (diaphragm replacement).

Designed by

When and where it was tested/implemented

Queen Elizabeth Central Hospital in Blantyre, Malawi

Funding Source

Finalist in Saving Lives at Birth Competition

References

Peer-reviewed publication

Other internally generated reports

Rice 360 Institute for Global Health Technologies. Bubble Continuous Positive Airway Pressure (bCPAP) Device in Malawi. Retreived December 3, 2013 from here.

Externally generated reports

Saving Lives at Birth. (2012). Low-Cost Respiratory Support: Reducing Early Neonatal Death in Malawi. Retrieved December 3, 2013 from here.

Boyd, Jade. (October 1 2013). UN Features Rice's Neonatal Breathing System. Rice University News & Media. Retrieved December 3, 2013

Williams, Mike. (July 30 2012). Rice's student-designed device to help babies breathe wins more support. Rice University News & Media. Retrieved December 3, 2013

Approval by regulatory bodies or standards boards

Page data
SDG SDG03 Good health and well-being, SDG09 Industry innovation and infrastructure
Authors Lonny Grafman, Chris Waterguy, Emilio, Kathleen Sienko, Amir Sabet Sarvestani
License CC-BY-SA-3.0
Organizations Appropedia Foundation, University of Michigan
Language English (en)
Related 0 subpages, 1 pages link here
Redirects Pumani bCPAP
Views 88 page views (analytics)
Created December 5, 2013 by Caroline Soyars
Last edit September 10, 2026 by Felipe Schenone